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 Antiadhesion therapy has been found to be a very promising means to 
prevent and treat infections in the respiratory, urinary, and gastrointestinal tract.  
Despite the considerable research interest in antiadhesives, relatively little is known 
about the ability of commercial dietary oligosaccharides, such as prebiotics, to inhibit 
pathogen adherence.  The goal of this research was to determine if commercially 
available prebiotic oligosaccharides could function as antiadhesive agents against 
enteropathogenic E. coli (EPEC).   
To investigate the ability of prebiotics to inhibit EPEC adherence, inhibition 
assays were performed by comparing adherence rates of EPEC on HEp-2 and 
Caco-2 cells in the presence of galactooligosaccharides (GOS), inulin, 
fructooligosaccharides, lactulose, or raffinose.  These data showed that GOS 
significantly reduced binding of EPEC more than the other prebiotics tested.  In 
addition, binding inhibition by GOS was shown to be dose-dependent and saturable 
at 16 mg/ml.  Microscopic analyses indicated that GOS also reduced the number of 
EPEC per microcolony and the total number of microcolonies per infected cell.   
Both therapeutic and prophylactic GOS treatments were also examined.  
GOS was unable to displace previously adhered EPEC, but could prevent EPEC 
adherence when administered prior to infection.  Additionally, GOS did not affect 
EPEC autoaggregation.  To determine if GOS was inhibiting adherence at a 
molecular level, the expression of BfpA, a bundle forming pili protein involved in 
localized adherence, was examined.  GOS did not affect BfpA expression indicating 
that adherence inhibition was not due to the absence of this adhesin.  
To further examine the role of EPEC adhesins in GOS-mediated adherence 
inhibition, adherence assays using HEp-2 and Caco-2 cell lines were performed 
using isogenic EPEC mutants.  In general, GOS did not affect the adherence of 
strains lacking BfpA, suggesting that GOS may interfere specifically with BfpA-
receptor interactions rather than with other potential EPEC adhesins and their 
receptors.  These results show that commercial prebiotics, particularly GOS, directly 
inhibit the adherence of E. coli, and provides evidence that these agents may be 
used as antiadhesives against pathogens in both humans and animals.   
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Preface 
 This dissertation consists of three chapters and a conclusions section.  
Chapter 1 is a literature review on bacterial adherence and the mechanisms by 
which adherence can be prevented.  Chapter 2 describes our published (Shoaf et 
al., 2006. Infect. Immun. In press) results focusing on the ability of prebiotic 
oligosaccharides to inhibit the binding of enteropathogenic Escherichia coli 
E2348/69 to two types of tissue culture cells.  In chapter 3, we report our results on 
the proposed Escherichia coli adhesins that may be involved in GOS-mediated 
adherence inhibition and the direct binding of Escherichia coli E2348/69 and other 
isogenic mutants to immobilized galactooligosaccharides.  Lastly, a conclusions 
section summarizes the major research findings presented within this dissertation 
and suggests areas for future research. 














































































































































































